|

HepB mAb19 Clinical Trials

2 actively recruiting trials across 1 location

Other1 trial

Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody (The SAMBA Study)
Phase 1

New York, New York1 trial

HepB mAb19 in Individuals With Chronic Hepatitis B Infection

NYU Langone Health

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.